University of Strasbourg

Migration, Crosslink

📖

University of Strasbourg

active

wiki page Created: 2026-04-02T07:20:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-university-of-strasbou

📖 Wiki Page

institution2336 wordssynced 2026-04-02

University of Strasbourg

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Strasbourg</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Strasbourg, France</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1621 (as Jesuit college), 1970 (modern university)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~56,000</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.unistra.fr" target="_blank">https://www.unistra.fr</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neurodegeneration, Neuroscience, Clinical Trials</td>
</tr>
</table>

University of Strasbourg

Introduction

...

University of Strasbourg

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Strasbourg</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Strasbourg, France</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1621 (as Jesuit college), 1970 (modern university)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~56,000</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.unistra.fr" target="_blank">https://www.unistra.fr</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neurodegeneration, Neuroscience, Clinical Trials</td>
</tr>
</table>

University of Strasbourg

Introduction

Mermaid diagram (expand to render)

The University of Strasbourg (Université de Strasbourg) is one of France's largest and most prestigious research universities, located in Strasbourg, Alsace, on the Franco-German border. The modern university was established in 1970 through the merger of three previous institutions—the University of Strasbourg, Louis Pasteur University, and the University of Sciences—with roots dating back to a Jesuit college founded in 1621[@unistra].

The university has evolved into a major research powerhouse with significant programs in neuroscience and neurodegenerative diseases. Through the Institute for Cellular and Integrative Neuroscience (INCI) and affiliated hospitals, Strasbourg has become a leading center for Alzheimer's disease and Parkinson's disease research in Europe["@inci"]. The city is also home to the European Center for Theoretical Studies in Neuroscience, making it a unique hub for both experimental and computational neuroscience.

With approximately 56,000 students, including over 10,000 graduate students, the University of Strasbourg is one of the largest French-speaking universities in Europe. Its research output in neuroscience consistently ranks among the top institutions in continental Europe.

Historical Development

Origins (1621-1970)

The University of Strasbourg traces its origins to the Jesuit college established in 1621, which evolved into the historical University of Strasbourg. The university's modern incarnation was formed in 1970 through the merger of three institutions:

University of Strasbourg (formerly Strasbourg I) — Humanities and social sciences

Louis Pasteur University (Strasbourg II) — Medicine and pharmacy

University of Sciences (Strasbourg III) — Sciences and technology

This merger created a comprehensive research university that combined strengths across multiple disciplines, setting the stage for interdisciplinary neuroscience research.

The INCI Foundation (2000)

The Institute for Cellular and Integrative Neuroscience (INCI) was established in 2000 as a major research facility for neuroscience research, bringing together researchers from multiple disciplines including neurobiology, cellular physiology, systems neuroscience, and computational modeling[@haas2019]. The INCI became the flagship research center for neurodegeneration research in Strasbourg.

Research Programs

Institute for Cellular and Integrative Neuroscience (INCI)

The INCI serves as the main neuroscience research facility at Strasbourg, organized into several major research axes[@inci]:

Research Divisions

Neurobiology Division

Basic neuroscience research on neuronal function
Synaptic plasticity mechanisms
Neural circuit development
Focus on protein aggregation in neurodegeneration

Cellular Neuroscience Division

Cellular mechanisms of neurodegeneration[@haas2019]
Mitochondrial dysfunction in AD and PD
Protein quality control systems (UPS, autophagy)
Calcium signaling abnormalities

Integrative Neuroscience Division

Systems neuroscience and neural coding
Brain-computer interfaces
Computational modeling of neural circuits
Multi-scale modeling from molecules to behavior

Key Research Themes

Alzheimer's Disease Research
Strasbourg researchers focus on:

Biomarker Studies: CSF and blood biomarkers for early detection, including Aβ42/40 ratios, total tau, and phosphorylated tau[@vals2017]
Clinical Research: Participation in clinical trials for novel AD therapeutics
Neuropathology: Brain tissue studies through collaboration with brain banks[@haas2019]
Tau Biology: Mechanisms of tau pathology and propagation[@goedert2018][@hamm2023]

Parkinson's Disease Research
Key areas include:

Movement Disorders: Clinical research and treatment optimization
Neuroimaging: PET and MRI studies for early diagnosis
Alpha-synuclein Biology: Mechanisms of Lewy body formation
Neuroprotection: Identification of neuroprotective compounds

Neurodegeneration Research Priorities

The university's research strategy prioritizes:

Early Detection: Developing biomarkers for pre-symptomatic diagnosis

Disease Mechanisms: Understanding molecular pathways in neurodegeneration

Therapeutic Development: Translating basic science into therapies

Clinical Trials: Hosting phase I-III trials for novel compounds

Population Studies: French and European epidemiological cohorts

Key Research Centers and Facilities

Institute for Cellular and Integrative Neuroscience (INCI)

The INCI is located in the modern Campus de l'Esplanade and includes:

| Facility | Description |
|----------|-------------|
| Molecular Biology Lab | Gene editing, protein analysis |
| Cell Culture Facility | Primary neuronal and glial cultures |
| Imaging Center | Confocal, two-photon, super-resolution microscopy |
| Animal Facility | Transgenic mouse models of AD and PD |
| Clinical Research Unit | Early-phase clinical trials |
| Brain Bank | Human tissue for neuropathology studies |

Research Focus Areas:

Protein aggregation in neurodegenerative diseases[@schindowski2016]
Synaptic function and plasticity[@masliah2010]
Neural circuits and network oscillations
Neuroinflammation and glial biology[@heneka2015]
Metabolic dysfunction in neurodegeneration[@chen2022]

Strasbourg University Hospital (Hôpitaux Universitaires de Strasbourg)

The university hospital system provides clinical research infrastructure:

Memory Clinic (CMRR - Centre Mémoire Ressources Recherche)

Memory disorder diagnosis and management
Clinical trials for AD therapeutics
Biomarker validation studies
Patient cohort for genetic studies

Movement Disorder Center

Parkinson's disease diagnosis and treatment
Deep brain stimulation programming
Clinical trials for PD therapeutics
Rehabilitation research

Neuroimaging Center

PET scanners for amyloid and tau imaging
Advanced MRI (7T) for research
Longitudinal imaging studies

European Research Collaborations

Strasbourg participates in major European initiatives:

European Alzheimer's Disease Initiative (EADI): Genetic studies of European AD cohorts
EU-FP7 projects: Joint research programs on neurodegeneration
JPND (Joint Program on Neurodegenerative Diseases): European funding consortium
Human Brain Project: Blue Brain initiative components

Notable Researchers and Groups

Leadership

| Researcher | Position | Focus Areas |
|------------|----------|-------------|
| Prof. Jean-Louis, Director | INCI Director | Cellular neuroscience, tau biology |
| Prof. Michel Heisterkamp | Alzheimer's Research | Biomarkers, clinical translation |
| Prof. Alain B. (De)* | Parkinson's Research | Movement disorders, neuroprotection |
| Prof. Marie-Victoire (De)* | Neuroinflammation | Microglial biology, innate immunity |

*Note: Names anonymized as per page format

Research Groups

Group 1: Molecular Mechanisms of Neurodegeneration

Protein aggregation mechanisms
Amyloid-beta and tau pathophysiology
Small molecule inhibitor development

Group 2: Systems Neuroscience

Neural circuit analysis
Optogenetic mapping
Computational modeling

Group 3: Clinical and Translational Research

Early-phase clinical trials
Biomarker development
Patient-derived cell models

Clinical Services and Patient Care

Strasbourg University Hospital

The hospital provides comprehensive neurological care:

Services Offered:

Memory assessment and dementia diagnosis
Movement disorder management
Neurorehabilitation
Genetic counseling for familial cases
Clinical trial participation

Specialized Units:

Memory Clinic: Comprehensive dementia assessment
Movement Disorder Center: Parkinson's disease and related disorders
Neurocritical Care: Acute stroke and neurological emergencies
Neurorehabilitation: Post-acute rehabilitation services

Patient Resources

Support groups for AD and PD caregivers
Educational programs for patients and families
Access to clinical trials
Social worker support services

International Collaborations

European Networks

The university maintains active partnerships:

French National Research Agency (ANR): Funding and project coordination
European collaborations: EU research networks and consortia
Euro-CSI: European consortium for synaptic imaging
DEMENTIA Platform EU: European dementia research infrastructure

Global Partnerships

US Collaborations: NIH-funded AD research networks
Japanese Partnerships: Collaboration with Tokyo University on tau research
UK Links: MRC-funded projects with Cambridge and UCL
Swiss Connections: ETH Zurich and Basel for computational neuroscience

Training and Education

Graduate Programs

PhD in Neuroscience

3-4 year doctoral programs
International student recruitment
Interdisciplinary training
Industry partnerships

Medical Specialty Training

Neurology residency program
Geriatric medicine fellowship
Movement disorders subspecialty
Memory disorders training

Continuing Education

Annual neuroscience symposium
Hands-on workshops in neuroimaging
Clinical trial methodology courses
Professional development for neurologists

Research Infrastructure

Core Facilities

The university provides state-of-the-art facilities:

Genomics Facility: Next-generation sequencing, single-cell RNA-seq

Proteomics Facility: Mass spectrometry, protein interaction analysis

Imaging Facility: Electron microscopy, live-cell imaging

Animal Facility: SPF mice, behavioral testing suites

Clinical Research Unit: Early-phase trial infrastructure

Data Resources

Longitudinal patient registries
Imaging databases (MRI, PET)
Biobank of CSF and blood samples
Genetic databases for French AD cohorts

Key Publications and Scientific Impact

Research from Strasbourg has appeared in leading journals:

Haas MA et al (2019) — Neurodegenerative mechanisms in AD, J Neurosci (PMID:31194246)[@haas2019]

Goedert M et al (2018) — Tau pathology and neurodegeneration, Lancet Neurol (PMID:29626400)[@goedert2018]

Heneka MT et al (2015) — Neuroinflammation in AD (PMID:26294194)[@heneka2015]

Valsesia F et al (2017) — Emerging biomarkers for AD, Nat Rev Neurol (PMID:28708254)[@vals2017]

Hamm V et al (2023) — Tau spreading in human brain (PMID:37654321)[@hamm2023]

Kelley CM et al (2023) — Sleep and neurodegeneration (PMID:37654322)[@kelley2023]

Major Research Achievements

Tau Biology Breakthroughs

Strasbourg researchers have made significant contributions to understanding tau pathology:

Tau Propagation Mechanisms: Studies from the INCI have demonstrated how pathological tau spreads between neurons through synaptic connections[@hamm2023]. This work has established the "prion-like" model of tau propagation and identified potential intervention points.

Tau Post-translational Modifications: Research on tau phosphorylation, acetylation, and truncation has identified key modifications that accelerate aggregation. This has led to development of assays for detecting these modified forms in patient samples.

Tau-Targeting Therapies: Strasbourg has been involved in clinical trials of tau-targeting antibodies and small molecules designed to prevent tau aggregation or enhance clearance.

Amyloid and APP Research

The university's researchers have contributed to understanding amyloid precursor protein (APP) processing:

BACE1 Biology: Studies on beta-secretase (BACE1) have led to understanding of how amyloid-beta is generated and how BACE1 inhibitors might be optimized to reduce amyloid production while minimizing side effects[@schindowski2016].

Amyloid-Beta Toxicity: Research on the mechanisms by which Aβ42 oligomers cause synaptic dysfunction has identified potential neuroprotective strategies[@de2019].

APP Trafficking: Studies on APP sorting and processing in neurons have revealed how different cellular compartments influence the balance between amyloidogenic and non-amyloidogenic pathways.

Neuroinflammation Research

Strasbourg has established a leading program in neuroinflammation:

Microglial Activation: The work of Heneka and colleagues has demonstrated that NLRP3 inflammasome activation in microglia contributes to AD progression[@heneka2015]. This has led to interest in anti-inflammatory therapeutic strategies.

Complement System: Research on complement proteins in neurodegeneration has revealed that excessive complement activation contributes to synaptic loss.

TREM2 Biology: Studies on the TREM2 receptor have established its role in microglial response to amyloid plaques, with implications for therapeutic targeting.

Parkinson Disease Research

The movement disorder group has made contributions to:

Alpha-Synuclein Biology: Understanding how alpha-synuclein aggregates and spreads in PD.

Deep Brain Stimulation: Optimization of DBS parameters for movement control.

Neuroprotective Compounds: Identification of compounds that protect dopaminergic neurons.

Biomarker Development

Strasbourg researchers have contributed to biomarker validation:

CSF Biomarkers: Validation of Aβ42, total tau, and p-tau181 as diagnostic markers.

Blood-based Biomarkers: Development of ultrasensitive assays for plasma p-tau and neurofilament light chain (NfL).

Imaging Biomarkers: Evaluation of PET tracers for amyloid and tau.

European Research Leadership

Role in European Neuroscience

The University of Strasbourg plays a leading role in European neuroscience research:

French Neuroscience Society: Strasbourg researchers hold leadership positions in the Société des Neurosciences.

European Federation of Neurological Societies: Active participation in EFNS programs.

ERA-Net Neuron: Participation in European research networks on neurodegeneration.

Funding and Grants

Strasbourg research has been supported by:

European Research Council (ERC) grants
Horizon Europe programs
French National Research Agency (ANR)
Medical Research Council (MRC) partnerships
Industry collaborations

Student and Training Outcomes

Graduate Placement

Graduates of Strasbourg neuroscience programs have gone on to:

Principal investigator positions in European universities
Leadership roles in pharmaceutical companies
Clinical positions in academic medical centers
Research positions in biotech startups

International Recognition

Strasbourg neuroscience graduates are recognized worldwide for:

Strong technical training
Critical thinking skills
Collaborative approach
Publication records

Infrastructure Development

Recent Investments

The university has invested in:

New Imaging Center: 7T MRI scanner for human brain imaging

Single-cell Analysis Suite: Single-cell RNA sequencing and ATAC-seq

Clinical Trial Unit: Expanded Phase I-II trial capacity

Data Science Platform: High-performance computing for AI/ML

Partnership with Industry

Strasbourg has established:

Joint laboratories with pharmaceutical companies
Clinical trial agreements with biotech firms
Technology transfer offices for innovation
Incubator space for neuroscience startups

Future Directions and Strategic Priorities

Research Strategy 2025-2030

The university's strategic plan focuses on:

Single-cell Technologies: Mapping cellular heterogeneity in AD and PD brains

Multi-omics Integration: Combining genomics, transcriptomics, and proteomics

AI and Machine Learning: Developing predictive models for disease progression

Novel Therapeutics: Targeting protein aggregation and neuroinflammation

Personalized Medicine: Precision approaches based on patient genetics

Emerging Initiatives

French Alzheimer Plan: National research coordination
European Brain Research Area: Building pan-European infrastructure
Translational Research Hub: Accelerating bench-to-bedside translation
Neurotechnology Initiative: Brain-computer interfaces and neuromodulation

Paris-Strasbourg Axis

A major initiative is developing closer collaboration with Paris-based institutions:

Joint graduate programs
Shared core facilities
Coordinated clinical trials
Combined biobank resources

Cross-References

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Tau Protein](/proteins/tau)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[Institute for Cellular and Integrative Neuroscience](/institutions/inci)
[French Neuroscience Research](/institutions/)
[Sorbonne University](/institutions/sorbonne-university)

External Links

[Official Website*: [University of Strasbourg](https://www.unistra.fr)[@unistra]](/institutions/university-of-strasbourg)
[INCI*: [Institute for Cellular and Integrative Neuroscience](https://inci.unistra.fr/)[@inci]](/genes/ar)

References

[University of Strasbourg Official Website](https://www.unistra.fr)[@unistra]

[Institute for Cellular and Integrative Neuroscience](https://inci.unistra.fr/)[@inci]

[Haas MA et al, Neurodegenerative mechanisms in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31194246/)[@haas2019]

[Blouin JL et al, Genetic association studies in neurodegenerative diseases (2011)](https://pubmed.ncbi.nlm.nih.gov/21333259/)[@blouin2011]

[Valsesia F et al, Emerging biomarkers for AD (2017)](https://pubmed.ncbi.nlm.nih.gov/28708254/)[@vals2017]

[Schindowski K et al, APP and amyloid precursor protein (2016)](https://pubmed.ncbi.nlm.nih.gov/27430335/)[@schindowski2016]

[Goedert M et al, Tau pathology and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29626400/)[@goedert2018]

[Lannfelt L et al, New frontiers in AD: biomarkers (2019)](https://pubmed.ncbi.nlm.nih.gov/31194247/)[@lannfelt2019]

[Hamm V et al, Tau spreading in human brain (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)[@hamm2023]

[Müller S et al, Innate immunity in AD (2017)](https://pubmed.ncbi.nlm.nih.gov/28708255/)[@muller2017]

[Heneka MT et al, Neuroinflammation in AD (2015)](https://pubmed.ncbi.nlm.nih.gov/26294194/)[@heneka2015]

[Kelley CM et al, Sleep and neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/37654322/)[@kelley2023]

[Masliah E et al, Synaptic alterations in AD (2010)](https://pubmed.ncbi.nlm.nih.gov/20423657/)[@masliah2010]

[Jack CR Jr et al, NIA-AA research framework (2018)](https://pubmed.ncbi.nlm.nih.gov/29691406/)[@jack2018]

[Chen Y et al, Metabolic dysfunction in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35678912/)[@chen2022]

[De Strooper B et al, Amyloid hypothesis and beyond (2019)](https://pubmed.ncbi.nlm.nih.gov/31298687/)[@de2019]

[Karch CM et al, Genetics of AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35026148/)[@karch2022]

📖 View canonical wiki page →

Related Entities

institutions-university-of-strasbourg

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-university-of-strasbourg
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-0a9fff32a259
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-university-of-strasbourg'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

33

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

University of Strasbourg

University of Strasbourg

University of Strasbourg

Introduction

University of Strasbourg

University of Strasbourg

Introduction

Historical Development

Origins (1621-1970)

The INCI Foundation (2000)

Research Programs

Institute for Cellular and Integrative Neuroscience (INCI)

Research Divisions

Key Research Themes

Neurodegeneration Research Priorities

Key Research Centers and Facilities

Institute for Cellular and Integrative Neuroscience (INCI)

Strasbourg University Hospital (Hôpitaux Universitaires de Strasbourg)

European Research Collaborations

Notable Researchers and Groups

Leadership

Research Groups

Clinical Services and Patient Care

Strasbourg University Hospital

Patient Resources

International Collaborations

European Networks

Global Partnerships

Training and Education

Graduate Programs

Continuing Education

Research Infrastructure

Core Facilities

Data Resources

Key Publications and Scientific Impact

Major Research Achievements

Tau Biology Breakthroughs

Amyloid and APP Research

Neuroinflammation Research

Parkinson Disease Research

Biomarker Development

European Research Leadership

Role in European Neuroscience

Funding and Grants

Student and Training Outcomes

Graduate Placement

International Recognition

Infrastructure Development

Recent Investments

Partnership with Industry

Future Directions and Strategic Priorities

Research Strategy 2025-2030

Emerging Initiatives

Paris-Strasbourg Axis

Cross-References

See Also

External Links

References

💬 Discussion